These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells. Muniyappa R; Xu R; Ram JL; Sowers JR Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1762-8. PubMed ID: 10843870 [TBL] [Abstract][Full Text] [Related]
23. Involvement of protein kinases in the induction of NO synthase II in human DLD-1 cells. Kleinert H; Euchenhofer C; Fritz G; Ihrig-Biedert I; Förstermann U Br J Pharmacol; 1998 Apr; 123(8):1716-22. PubMed ID: 9605580 [TBL] [Abstract][Full Text] [Related]
24. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway. Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187 [TBL] [Abstract][Full Text] [Related]
25. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis. Kuwahara N; Sasaki S; Kobara M; Nakata T; Tatsumi T; Irie H; Narumiya H; Hatta T; Takeda K; Matsubara H; Hushiki S Int J Cardiol; 2008 Jan; 123(2):84-90. PubMed ID: 17434618 [TBL] [Abstract][Full Text] [Related]
26. Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts. Madonna R; Di Napoli P; Massaro M; Grilli A; Felaco M; De Caterina A; Tang D; De Caterina R; Geng YJ J Biol Chem; 2005 Apr; 280(14):13503-11. PubMed ID: 15705589 [TBL] [Abstract][Full Text] [Related]
27. HMG-CoA reductase inhibitors induce COX-2 gene expression in murine macrophages: role of MAPK cascades and promoter elements for CREB and C/EBPbeta. Chen JC; Huang KC; Wingerd B; Wu WT; Lin WW Exp Cell Res; 2004 Dec; 301(2):305-19. PubMed ID: 15530865 [TBL] [Abstract][Full Text] [Related]
28. Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I. Martin G; Duez H; Blanquart C; Berezowski V; Poulain P; Fruchart JC; Najib-Fruchart J; Glineur C; Staels B J Clin Invest; 2001 Jun; 107(11):1423-32. PubMed ID: 11390424 [TBL] [Abstract][Full Text] [Related]
29. Statin treatment and 3' polyadenylation of eNOS mRNA. Kosmidou I; Moore JP; Weber M; Searles CD Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2642-9. PubMed ID: 17916773 [TBL] [Abstract][Full Text] [Related]
31. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury. Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146 [TBL] [Abstract][Full Text] [Related]
32. Interaction between nitric oxide synthase and cyclooxygenase pathways in osteoblastic MC3T3-E1 cells. Kanematsu M; Ikeda K; Yamada Y J Bone Miner Res; 1997 Nov; 12(11):1789-96. PubMed ID: 9383683 [TBL] [Abstract][Full Text] [Related]
33. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells. Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111 [TBL] [Abstract][Full Text] [Related]
34. Rho protein-mediated changes in the structure of the actin cytoskeleton regulate human inducible NO synthase gene expression. Witteck A; Yao Y; Fechir M; Förstermann U; Kleinert H Exp Cell Res; 2003 Jul; 287(1):106-15. PubMed ID: 12799187 [TBL] [Abstract][Full Text] [Related]